InvestorsHub Logo
Followers 4
Posts 1242
Boards Moderated 0
Alias Born 01/16/2016

Re: Ecco post# 1415

Tuesday, 03/22/2016 3:11:15 PM

Tuesday, March 22, 2016 3:11:15 PM

Post# of 6602
Let's keep an eye on fundamentals

Evidence of usefulness: Many studies are underway and will be completed in the next few years

http://ir.eksobionics.com/press-releases/detail/563/ekso-bionics-announces-new-clinical-trial-underway-in-europe

https://globenewswire.com/news-release/2016/02/03/807455/0/en/Kessler-Foundation-Receives-1-M-Grant-to-Study-Benefits-of-Ekso-Bionics-Ekso-GT-Exoskeleton.html

Increasing Sales:

"Shipped 15 units and converted 2 rental units to purchases in the fourth quarter, expanding the installed base to over 170 medical devices at over 115 customers."

Increasing Revenue:

"Revenues of $1.9 million for the fourth quarter of 2015, compared to $1.5 million for the same period in the prior year."

"Engineering services revenue increased by $2.0 million, or 83%, to $4.4 million for 2015 compared to $2.4 million in the prior year. This increase was primarily due to an overall increase in revenue generating projects."

More Contracts:

"http://ir.eksobionics.com/press-releases/detail/566/ekso-bionics-selected-for-development-of-next-generation";

Other people buying Ekso stock:

"Entered into a definitive agreement with certain healthcare focused institutional investors for the sale of 15,000 shares of Series A Convertible Preferred Stock and warrants to purchase 14,851,486 shares of the Company’s common stock. The net proceeds to the Company from this offering were $13.9 million."

What has changed, fundamentally speaking, that has cause for concern? If there is something I am missing, I would like to know.


The CEO being removed off the board is a little scary, but without evidence of any wrong doing - I'm not sure it is worth reacting over. The value of the CEO is less intrinsic than most other fundamentals in my view. Revenue numbers are a lot more quantitative to me.

Missing earnings might be the only truly negative event. Missing by 2 cents per share isn't too terrible, I'm okay with that.

I don't think the Boston Dynamics thing is a big deal, Ekso has already received the 4th contract with DARPA and with out Google.

My opinion is that unless Ekso Bionics admits to fraud or has their products recalled by the FDA - I'm in it for the long run based on the current information.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EKSO News